Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?

Dick, 2008, Stem cell concepts renew cancer research, Blood, 112, 4793, 10.1182/blood-2008-08-077941 McCulloch, 1981, The heritable nature of clonal characteristics in acute myeloblastic leukemia, Blood, 58, 105, 10.1182/blood.V58.1.105.105 McCulloch, 1983, Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982), Blood, 62, 1, 10.1182/blood.V62.1.1.1 Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat Med, 3, 730, 10.1038/nm0797-730 Lapidot, 1994, A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0 Larochelle, 1996, Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy, Nat Med, 2, 1329, 10.1038/nm1296-1329 Haase, 1995, Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations, Blood, 86, 2906, 10.1182/blood.V86.8.2906.2906 Jordan, 2000, The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells, Leukemia, 14, 1777, 10.1038/sj.leu.2401903 Jaiswal, 2009, CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis, Cell, 138, 271, 10.1016/j.cell.2009.05.046 Legras, 1998, A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia, Blood, 91, 3401, 10.1182/blood.V91.9.3401 Testa, 2002, Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis, Blood, 100, 2980, 10.1182/blood-2002-03-0852 Majeti, 2009, CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells, Cell, 138, 286, 10.1016/j.cell.2009.05.045 de Jonge-Peeters, 2007, ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance, Crit Rev Oncol Hematol, 62, 214, 10.1016/j.critrevonc.2007.02.003 Steelman, 2008, Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia, Leukemia, 22, 686, 10.1038/leu.2008.26 Guzman, 2001, Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells, Blood, 98, 2301, 10.1182/blood.V98.8.2301 Hong, 2008, Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia, Science, 319, 336, 10.1126/science.1150648 Wilson, 2010, Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia, Haematologica, 95, 679, 10.3324/haematol.2009.011726 Bernt, 2009, Leukemia stem cells and human acute lymphoblastic leukemia, Semin Hematol, 46, 33, 10.1053/j.seminhematol.2008.09.010 Cozzio, 2003, Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors, Genes Dev, 17, 3029, 10.1101/gad.1143403 Huntly, 2004, MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors, Cancer Cell, 6, 587, 10.1016/j.ccr.2004.10.015 Krivtsov, 2006, Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9, Nature, 442, 818, 10.1038/nature04980 Minden, 1978, Proliferative state of blast cell progenitors in acute myeloblastic leukemia (AML), Blood, 52, 592, 10.1182/blood.V52.3.592.592 Guan, 2003, Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML), Blood, 101, 3142, 10.1182/blood-2002-10-3062 Calvi, 2003, Osteoblastic cells regulate the haematopoietic stem cell niche, Nature, 425, 841, 10.1038/nature02040 Zhang, 2003, Identification of the haematopoietic stem cell niche and control of the niche size, Nature, 425, 836, 10.1038/nature02041 Kopp, 2005, The bone marrow vascular niche: home of HSC differentiation and mobilization, Physiology (Bethesda), 20, 349, 10.1152/physiol.00025.2005 Kiel, 2008, Uncertainty in the niches that maintain haematopoietic stem cells, Nat Rev Immunol, 8, 290, 10.1038/nri2279 Sugiyama, 2006, Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches, Immunity, 25, 977, 10.1016/j.immuni.2006.10.016 Ara, 2003, Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny, Immunity, 19, 257, 10.1016/S1074-7613(03)00201-2 Spiegel, 2007, Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling, Nat Immunol, 8, 1123, 10.1038/ni1509 Katayama, 2006, Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow, Cell, 124, 407, 10.1016/j.cell.2005.10.041 Eliasson, 2010, The hematopoietic stem cell niche: low in oxygen but a nice place to be, J Cell Physiol, 222, 17, 10.1002/jcp.21908 Prosper, 2001, Regulation of hematopoiesis through adhesion receptors, J Leukoc Biol, 69, 307, 10.1189/jlb.69.3.307 Wilson, 2006, Bone-marrow haematopoietic-stem-cell niches, Nat Rev Immunol, 6, 93, 10.1038/nri1779 McCulloch, 1965, The cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype Sl-Sld, Blood, 26, 399, 10.1182/blood.V26.4.399.399 Czechowicz, 2007, Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches, Science, 318, 1296, 10.1126/science.1149726 Kiel, 2009, Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance, Cell Stem Cell, 4, 170, 10.1016/j.stem.2008.10.005 Hosokawa, 2010, Cadherin-based adhesion is a potential target for niche manipulation to protect hematopoietic stem cells in adult bone marrow, Cell Stem Cell, 6, 194, 10.1016/j.stem.2009.04.013 Nilsson, 2005, Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells, Blood, 106, 1232, 10.1182/blood-2004-11-4422 Arai, 2004, Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche, Cell, 118, 149, 10.1016/j.cell.2004.07.004 Zou, 1998, Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development, Nature, 393, 595, 10.1038/31269 Tachibana, 1998, The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract, Nature, 393, 591, 10.1038/31261 Peled, 1999, Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4, Science, 283, 845, 10.1126/science.283.5403.845 Kollet, 2001, Rapid and efficient homing of human CD34(+)CD38(−/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice, Blood, 97, 3283, 10.1182/blood.V97.10.3283 Peled, 2000, The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice, Blood, 95, 3289, 10.1182/blood.V95.11.3289 Avigdor, 2004, CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow, Blood, 103, 2981, 10.1182/blood-2003-10-3611 Méndez-Ferrer, 2008, Haematopoietic stem cell release is regulated by circadian oscillations, Nature, 452, 442, 10.1038/nature06685 Liles, 2003, Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist, Blood, 102, 2728, 10.1182/blood-2003-02-0663 Lataillade, 2000, Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival, Blood, 95, 756, 10.1182/blood.V95.3.756 Broxmeyer, 2003, Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells, J Leukoc Biol, 73, 630, 10.1189/jlb.1002495 Rosu-Myles, 2003, SDF-1 enhances the expansion and maintenance of highly purified human hematopoietic progenitors, Hematol J, 4, 137, 10.1038/sj.thj.6200233 Broxmeyer, 2003, Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo, J Immunol, 170, 421, 10.4049/jimmunol.170.1.421 Hérodin, 2003, Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma-irradiation promotes survival, Blood, 101, 2609, 10.1182/blood-2002-06-1634 Ponomaryov, 2000, Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function, J Clin Invest, 106, 1331, 10.1172/JCI10329 Janowska-Wieczorek, 2000, Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines, Exp Hematol, 28, 1274, 10.1016/S0301-472X(00)00532-4 Petit, 2005, Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells, J Clin Invest, 115, 168, 10.1172/JCI200521773 Busillo, 2010, Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling, J Biol Chem, 285, 7805, 10.1074/jbc.M109.091173 Burns, 2006, A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development, J Exp Med, 203, 2201, 10.1084/jem.20052144 Sierro, 2007, Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7, Proc Natl Acad Sci USA, 104, 14759, 10.1073/pnas.0702229104 Ishikawa, 2007, Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region, Nat Biotechnol, 25, 1315, 10.1038/nbt1350 Saito, 2010, Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML, Nat Biotechnol, 28, 275, 10.1038/nbt.1607 Mortensen, 1998, Changing bone marrow micro-environment during development of acute myeloid leukaemia in rats, Br J Haematol, 102, 458, 10.1046/j.1365-2141.1998.00801.x Wellmann, 2004, Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF, Leukemia, 18, 926, 10.1038/sj.leu.2403332 Colmone, 2008, Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells, Science, 322, 1861, 10.1126/science.1164390 Mowafi, 2008, Chemokine CXCL12 enhances proliferation in pre-B-ALL via STAT5 activation, Pediatr Blood Cancer, 50, 812, 10.1002/pbc.21370 Mirshahi, 2009, Vasculogenic mimicry of acute leukemic bone marrow stromal cells, Leukemia, 23, 1039, 10.1038/leu.2009.10 Hussong, 2000, Evidence of increased angiogenesis in patients with acute myeloid leukemia, Blood, 95, 309, 10.1182/blood.V95.1.309 Koomagi, 2001, Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction, Clin Cancer Res, 7, 3381 Sipkins, 2005, In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment, Nature, 435, 969, 10.1038/nature03703 Walkley, 2007, A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency, Cell, 129, 1097, 10.1016/j.cell.2007.05.014 Raaijmakers, 2010, Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia, Nature, 464, 852, 10.1038/nature08851 Bendall, 2005, Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia, Cancer Res, 65, 3290, 10.1158/0008-5472.CAN-04-3402 Tavor, 2004, CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice, Cancer Res, 64, 2817, 10.1158/0008-5472.CAN-03-3693 Möhle, 1998, The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1, Blood, 91, 4523, 10.1182/blood.V91.12.4523 Möhle, 2000, Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia, Br J Haematol, 110, 563, 10.1046/j.1365-2141.2000.02157.x Spoo, 2007, CXCR4 is a prognostic marker in acute myelogenous leukemia, Blood, 109, 786, 10.1182/blood-2006-05-024844 Konoplev, 2007, Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype, Cancer, 109, 1152, 10.1002/cncr.22510 Fiegl, 2009, CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure, Blood, 113, 1504, 10.1182/blood-2008-06-161539 Petit, 2002, G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4, Nat Immunol, 3, 687, 10.1038/ni813 Tavor, 2005, Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice, Blood, 106, 2120, 10.1182/blood-2004-12-4969 Fukuda, 2005, Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis, Blood, 105, 3117, 10.1182/blood-2004-04-1440 Rombouts, 2004, Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia, Blood, 104, 550, 10.1182/blood-2004-02-0566 Fazio, 2008, PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells, Cancer Res, 68, 181, 10.1158/0008-5472.CAN-07-2778 Grundler, 2009, Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration, J Exp Med, 206, 1957, 10.1084/jem.20082074 Rubin, 2009, Chemokine signaling in cancer: one hump or two?, Semin Cancer Biol, 19, 116, 10.1016/j.semcancer.2008.10.001 Juarez, 2007, Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia, Haematologica, 92, 450, 10.3324/haematol.10621 Scupoli, 2008, Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways, Haematologica, 93, 524, 10.3324/haematol.12098 Spiegel, 2004, Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling, Blood, 103, 2900, 10.1182/blood-2003-06-1891 Shen, 2001, The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow, Exp Hematol, 29, 1439, 10.1016/S0301-472X(01)00741-X Bradstock, 2000, Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers, Leukemia, 14, 882, 10.1038/sj.leu.2401729 Juarez, 2009, CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK, Br J Haematol, 145, 491, 10.1111/j.1365-2141.2009.07648.x Liesveld, 2007, Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells, Leuk Res, 31, 1553, 10.1016/j.leukres.2007.02.017 Tavor, 2008, The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation, Leukemia, 22, 2151, 10.1038/leu.2008.238 Jacobi, 2010, Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts, Exp Hematol, 38, 180, 10.1016/j.exphem.2009.12.003 Nagasawa, 1994, Molecular cloning and structure of a pre-B-cell growth-stimulating factor, Proc Natl Acad Sci USA, 91, 2305, 10.1073/pnas.91.6.2305 Juarez, 2003, Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro, Leukemia, 17, 1294, 10.1038/sj.leu.2402998 Nishii, 1999, Survival of human leukaemic B-cell precursors is supported by stromal cells and cytokines: association with the expression of bcl-2 protein, Br J Haematol, 105, 701, 10.1046/j.1365-2141.1999.01380.x Bendall, 1994, Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells, Exp Hematol, 22, 1252 Konopleva, 2002, Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins, Leukemia, 16, 1713, 10.1038/sj.leu.2402608 Matsunaga, 2003, Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia, Nat Med, 9, 1158, 10.1038/nm909 Becker, 2009, Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia, Blood, 113, 866, 10.1182/blood-2007-12-124818 Peled, 1999, The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow, J Clin Invest, 104, 1199, 10.1172/JCI7615 Charrad, 1999, Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia, Nat Med, 5, 669, 10.1038/9518 Jin, 2006, Targeting of CD44 eradicates human acute myeloid leukemic stem cells, Nat Med, 12, 1167, 10.1038/nm1483 McCubrey, 2008, Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy, Leukemia, 22, 708, 10.1038/leu.2008.27 Guzman, 2007, An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells, Blood, 110, 4427, 10.1182/blood-2007-05-090621 Jordan, 2008, Can we finally target the leukemic stem cells?, Best Pract Res Clin Haematol, 21, 615, 10.1016/j.beha.2008.07.006 Jin, 2009, Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells, Cell Stem Cell, 5, 31, 10.1016/j.stem.2009.04.018 Ravandi, 2006, Role of cytokines in the treatment of acute leukemias: a review, Leukemia, 20, 563, 10.1038/sj.leu.2404152 Zeng, 2009, Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML, Blood, 113, 6215, 10.1182/blood-2008-05-158311 Nervi, 2009, Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100, Blood, 113, 6206, 10.1182/blood-2008-06-162123 Fruehauf, 2009, A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European Phase II Study, Cytotherapy, 11, 992, 10.3109/14653240903121245 Burger, 2009, CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers, Leukemia, 23, 43, 10.1038/leu.2008.299 Kalatskaya, 2009, AMD3100 is a CXCR7 ligand with allosteric agonist properties, Mol Pharmacol, 75, 1240, 10.1124/mol.108.053389 Abraham, 2009, The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation, Leukemia, 23, 1378, 10.1038/leu.2009.56 Uy, 2008, Mobilization and Chemosensitization of AML with the CXCR4 Antagonist Plerixafor (AMD3100): a Phase I/II study of AMD3100+MEC in patients with relapsed or refractory disease, Blood, 112, 10.1182/blood.V112.11.1944.1944